window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Master Data Management

  • Biotech & Pharma Business,Digital & Data

    Turning AI Skeptics into AI Advocates Through High-Integrity Data

    With 89% of AI pilots failing to scale, biopharmas can [...]

    May 14, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    5 Insights on Data Foundations From Top Pharma Leaders

    As the pharmaceutical industry moves from AI experimentation to execution, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Manufacturing & Supply Chain

    IQVIA and Veeva agree global clinical and commercial collaboration

    IQVIA and Veeva Systems have announced the resolution of all [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • RxLogix launches AI pharmacovigilance platform for adverse event monitoring
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development
  • Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top